Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
“Pretreatment of the injection site with proinflammatory compounds or TLR-agonists such as imiquimode (TLR7) have been shown to significantly enhance both the persistence and trafficking of DCs into the draining lymph nodes after vaccination, resulting in increased priming of tumor-specific T cells (167, 181, 204).”
BackgroundCCR7 and its ligands: balancing immunity and tolerance
Förster, R., Davalos-Misslitz, A. C., & Rot, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2297 · Cited by 1,410
“Furthermore, DCs differentiated from the bone marrow of CCR7-deficient mice do not migrate to the draining lymph nodes following their subcutaneous injection or intra-tracheal instillatio”
BackgroundInduced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
“The number of DCs and their maturation state affect the efficiency of T cell priming and the quality of the developing T cell respons”
BackgroundSelf-citationBiological applications of magnetic nanoparticles
Colombo, M., Carregal-Romero, S., Casula, M. F., Gutiérrez, L., Morales, M. P., Böhm, I. B., Heverhagen, J. T., Prosperi, D., & Parak, W. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15337h · Cited by 1,315
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
“DC responsiveness to lymphatic CCL19 is supported by a second autocrine signal in the form of cysteinylated leukotrienes (186).”
BackgroundInfluentialDendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
“In a mouse study, conditioning the injection site with TNF markedly increased both the migration of DCs to the draining lymph nodes and the magnitude of the CD4 + T-cell respons”
BackgroundDendritic-cell trafficking to lymph nodes through lymphatic vessels
Randolph, G. J., Angeli, V., & Swartz, M. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1670 · Cited by 1,111
“fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1236">CCR7 ), to migrate to lymph nodes through peripheral lymphatic vessel”
BackgroundCCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions
Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., & Förster, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.014 · Cited by 1,086
Garris, C. S., Arlauckas, S. P., Kohler, R. H., Trefny, M. P., Garren, S., Piot, C., Engblom, C., Pfirschke, C., Siwicki, M., Gungabeesoon, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.024 · Cited by 966
“Interestingly, these DCs may be involved at different stages during the tumor rejection process: besides their critical role for priming T cells in lymph nodes (MartIn-Fontecha et al., 2003), recent studies demonstrated that DCs can be found in tumors, where they recruit T cells and stimulate tumor-reactive T cell res…”
Dendritic cell immunotherapy: mapping the way
Figdor, C. G., de Vries, I. J. M., Lesterhuis, W. J., & Melief, C. J. M. (2004) · Nature Medicine · doi:10.1038/nm1039 · Cited by 945
Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 855
Dendritic cell subsets in T cell programming: location dictates function
Eisenbarth, S. C. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0088-1 · Cited by 827
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
Cyster, J. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115628 · Cited by 856
Dendritic Cells: Translating Innate to Adaptive Immunity
Steinman, R. M., & Hemmi, H. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-32636-7_2 · Cited by 844
“an increased expression of CCR7 on the DCs [52] as well as the corresponding chemokines, CCL19 and 21 on lymphatics and in the lymph node [53, 54].”
BackgroundANTIGEN-SPECIFIC MEMORY B CELL DEVELOPMENT
McHeyzer-Williams, L. J., & McHeyzer-Williams, M. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115732 · Cited by 725
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Generation and Biological Activities of Oxidized Phospholipids
Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., Levonen, A.-L., Binder, C. J., & Stöckl, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2597 · Cited by 610
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
Interstitial leukocyte migration and immune function
Friedl, P., & Weigelin, B. (2008) · Nature Immunology · doi:10.1038/ni.f.212 · Cited by 587
Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G., Muller, W. A., Moretta, L., & Münz, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407522101 · Cited by 583
Adhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584
Gilboa, E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31205 · Cited by 588
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
How Tolerogenic Dendritic Cells Induce Regulatory T Cells
Maldonado, R. A., & von Andrian, U. H. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 541
“CCR7 deficiency impairs lymphatic migration of iDCs and compromises the induction of inhaled and oral tolerance (Förster et al., 2008; Martin-Fontecha et al., 2003).”
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
Hackstein, H., & Thomson, A. W. (2004) · Nature Reviews Immunology · doi:10.1038/nri1256 · Cited by 545
“cgi?l=6366">CCL21 , that guide migration to secondary lymphoid organ”
BackgroundMechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
“These findings were later substantiated by studies in Ccr7 / mice (Forster et al., 1999; Martin-Fontecha et al., 2003; Ohl et al., 2004).”
BackgroundResultTetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Mitchell, D. A., Batich, K. A., Gunn, M. D., Huang, M.-N., Sanchez-Perez, L., Nair, S. K., Congdon, K. L., Reap, E. A., Archer, G. E., Desjardins, A., et al. (2015) · Nature · doi:10.1038/nature14320 · Cited by 531
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
Dendritic Cells and Their Role in Immunotherapy
Gardner, A., de Mingo Pulido, Á., & Ruffell, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00924 · Cited by 485
Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues
Debes, G. F., Arnold, C. N., Young, A. J., Krautwald, S., Lipp, M., Hay, J. B., & Butcher, E. C. (2005) · Nature Immunology · doi:10.1038/ni1238 · Cited by 474
“CCL21-expressing lymphatics can be visualized immunohistochemically in skin, mainly adjacent to venules involved in lymphocyte recruitment or immediately underlying the epitheliu”
BackgroundSelf-citationDendritic cell subsets in health and disease
Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00551.x · Cited by 430
“Studies in mice show that preinjection of TNF at the site of the DC vaccination greatly improves the migration of DCs to the draining lymphoid tissue and the magnitude of induced immunity (348).”
BackgroundB Cell-Driven Lymphangiogenesis in Inflamed Lymph Nodes Enhances Dendritic Cell Mobilization
Angeli, V., Ginhoux, F., Llodrà, J., Quemeneur, L., Frenette, P. S., Skobe, M., Jessberger, R., Merad, M., & Randolph, G. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.003 · Cited by 424
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis
Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S. H. E., & Schaible, U. E. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.001 · Cited by 395
Immunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
Chemokines: key players in innate and adaptive immunity
Esche, C., Stellato, C., & Beck, L. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23841.x · Cited by 385
“But CCL21 can also be induced on afferent lymphatics by inflammatory stimuli, thereby boosting the numbers of DC that reach the draining lymph node (see Leukocyte recruitment)”
BackgroundXu, Y., Zhan, Y., Lew, A. M., Naik, S. H., & Kershaw, M. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7577 · Cited by 375
Villablanca, E. J., Raccosta, L., Zhou, D., Fontana, R., Maggioni, D., Negro, A., Sanvito, F., Ponzoni, M., Valentinis, B., Bregni, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2074 · Cited by 335
“This process requires the expression of the lymphoid-homing receptor CCR7 by maturing DC”
BackgroundBuckley, C. D., Ross, E. A., McGettrick, H. M., Osborne, C. E., Haworth, O., Schmutz, C., Stone, P. C. W., Salmon, M., Matharu, N. M., Vohra, R. K., et al. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905496 · Cited by 340
“As differentiated cells, they retain the ability to migrate out of the tissue via the afferent lymphatic vasculature and accumulate within secondary lymphoid tissues [3, 4].”
BackgroundTrogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J., & Fisher, E. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511043103 · Cited by 346
An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium
Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D., & Jackson, D. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051759 · Cited by 346
Potteaux, S., Gautier, E. L., Hutchison, S. B., van Rooijen, N., Rader, D. J., Thomas, M. J., Sorci-Thomas, M. G., & Randolph, G. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43802 · Cited by 334
Manipulating dendritic cell biology for the active immunotherapy of cancer
O'Neill, D. W., Adams, S., & Bhardwaj, N. (2004) · Blood · doi:10.1182/blood-2003-12-4392 · Cited by 339
“Ex vivo-derived DCs can also be matured in situ by pre-conditioning the injection site with TLR agonists,(118) and DC migration can be enhanced by pre-conditioning the injection site with cytokines or with DCs themselves.(7,119,120) This approach may be preferable to ex vivo maturation, since DC cytokines”
BackgroundSchumann, K., Lämmermann, T., Bruckner, M., Legler, D. F., Polleux, J., Spatz, J. P., Schuler, G., Förster, R., Lutz, M. B., Sorokin, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.017 · Cited by 324
“Solubilization of chemokines might further support collective movement patterns as they have been described for DCs: here, migrating cells locally recruit more cells into the lymph node, a phenomenon that has been described as lymph node conditioning (Martín- Fontecha et al., 2003).”
BackgroundBraun, A., Worbs, T., Moschovakis, G. L., Halle, S., Hoffmann, K., Bölter, J., Münk, A., & Förster, R. (2011) · Nature Immunology · doi:10.1038/ni.2085 · Cited by 337
“It is well established that after subcutaneous injection of DCs, only a small fraction of wild-type DCs actually enters the afferent lymphatic vessels and subsequently the connecting lymph nod”
BackgroundCCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells
Schneider, M. A., Meingassner, J. G., Lipp, M., Moore, H. D., & Rot, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061405 · Cited by 321
Self-citationValladeau, J., & Saeland, S. (2005) · Seminars in Immunology · doi:10.1016/j.smim.2005.05.009 · Cited by 297
Cahalan, M. D., & Parker, I. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090620 · Cited by 302
Comerford, I., Harata-Lee, Y., Bunting, M. D., Gregor, C., Kara, E. E., & McColl, S. R. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.001 · Cited by 289
Immune mechanisms of allergen‐specific sublingual immunotherapy
Moingeon, P., Batard, T., Fadel, R., Frati, F., Sieber, J., & Van Overtvelt, L. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01002.x · Cited by 290
“Importantly, the magnitude of CD4T-cell responses elicited within lymph nodes is directly proportional to the number of allergencarrying DCs that migrate to lymph nodes, which clearly represents a limiting step (121).”
BackgroundSemaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II
Takamatsu, H., Takegahara, N., Nakagawa, Y., Tomura, M., Taniguchi, M., Friedel, R. H., Rayburn, H., Tessier-Lavigne, M., Yoshida, Y., Okuno, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1885 · Cited by 288
Yoneyama, H., Matsuno, K., Zhang, Y., Nishiwaki, T., Kitabatake, M., Ueha, S., Narumi, S., Morikawa, S., Ezaki, T., Lu, B., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh093 · Cited by 270
“( 45 ). (vi) In contrast, pDC precursors transmigrate across activated HEVs in a CXCL9 and E-selectin dependent manner.”
BackgroundThe Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells
Sánchez-Sánchez, N., Riol-Blanco, L., & Rodríguez-Fernández, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5153 · Cited by 273
“In this regard, it has been reported that the number of DCs that reach the lymph nodes may positively affect the immune response (33).”
BackgroundForm follows function: lymphoid tissue microarchitecture in antimicrobial immune defence
Junt, T., Scandella, E., & Ludewig, B. (2008) · Nature Reviews Immunology · doi:10.1038/nri2414 · Cited by 267
“FRC-associated DCs in the lymph node may also become targets of these chemokines: inflammation in the periphery upregulates the expression of CC-chemokine ligand 21 ( CCL21 ) by the endothelial cells of afferent lymph vessel”
BackgroundMesenchymal stem cells impair in vivo T-cell priming by dendritic cells
Chiesa, S., Morbelli, S., Morando, S., Massollo, M., Marini, C., Bertoni, A., Frassoni, F., Bartolomé, S. T., Sambuceti, G., Traggiai, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103650108 · Cited by 269
“As a consequence, the total number of DC migrating in the draining lymph nodes deeply affects naive T-cell priming (6).”
BackgroundChemokine and chemotactic signals in dendritic cell migration
Tiberio, L., Del Prete, A., Schioppa, T., Sozio, F., Bosisio, D., & Sozzani, S. (2018) · Cellular & Molecular Immunology · doi:10.1038/s41423-018-0005-3 · Cited by 256
Tal, O., Lim, H. Y., Gurevich, I., Milo, I., Shipony, Z., Ng, L. G., Angeli, V., & Shakhar, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102392 · Cited by 269
“As corroborated in knockout mice, without engagement of CCR7 DCs do not enter lymphatics and do not appear in LNs several hours later (Förster et al., 1999; Martín-Fontecha et al., 2003; Ohl et al., 2004).”
BackgroundMunn, D. H., & Mellor, A. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.11.003 · Cited by 259
Generation of gut‐homing T cells and their localization to the small intestinal mucosa
Johansson‐Lindbom, B., & Agace, W. W. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00482.x · Cited by 250
“tion, they failed to express CCR9 and displayed reduced levels of a4b7 (58).”
BackgroundBenne, N., van Duijn, J., Kuiper, J., Jiskoot, W., & Slütter, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.033 · Cited by 248
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis
Kingston, D., Schmid, M. A., Onai, N., Obata-Onai, A., Baumjohann, D., & Manz, M. G. (2009) · Blood · doi:10.1182/blood-2009-02-206318 · Cited by 236
Lymph node homing of T cells and dendritic cells via afferent lymphatics
Förster, R., Braun, A., & Worbs, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.007 · Cited by 228
Initiation of Immune Responses in Brain Is Promoted by Local Dendritic Cells
Karman, J., Ling, C., Sandor, M., & Fabry, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2353 · Cited by 240
“5–1% of injected GFP-DCs were found in cervical LNs at this time point, which corresponds to data published recently (25) quantifying the amount of injected DCs migrating out of the skin.”
BackgroundThe secretion of HMGB1 is required for the migration of maturing dendritic cells
Dumitriu, I. E., Bianchi, M. E., Bacci, M., Manfredi, A. A., & Rovere-Querini, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306171 · Cited by 247
“After detection and capture of microbes in peripheral tissues, DC disassemble the actinbased cytoskeleton [17] and up-regulate the expression of receptors to chemokines, which are constitutively expressed in secondary lymphoid organs such as lymph nodes and spleen [18, 19], where they meet and activate (or tolerize) a…”
BackgroundImmune system targeting by biodegradable nanoparticles for cancer vaccines
Silva, J. M., Videira, M., Gaspar, R., Préat, V., & Florindo, H. F. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.010 · Cited by 233
The Regulation of Inflammation by Innate and Adaptive Lymphocytes
Cronkite, D. A., & Strutt, T. M. (2018) · Journal of Immunology Research · doi:10.1155/2018/1467538 · Cited by 222
“Cohorts of APC, once activated, will begin to migrate towards lymphoid organ chemokines CCL19 and CCL21 in a CCR7-dependent fashion [97, 98].”
Mayer, C. T., Ghorbani, P., Nandan, A., Dudek, M., Arnold-Schrauf, C., Hesse, C., Berod, L., Stüve, P., Puttur, F., Merad, M., et al. (2014) · Blood · doi:10.1182/blood-2013-12-545772 · Cited by 219
“Only about 1% of DCs migrate to lymph nodes after subcutaneous injection.(17) Around 10(4) DCs populate mouse lymph nodes at steady state, representing about 0.”
BackgroundInnate control of actin nucleation determines two distinct migration behaviours in dendritic cells
Vargas, P., Maiuri, P., Bretou, M., Sáez, P. J., Pierobon, P., Maurin, M., Chabaud, M., Lankar, D., Obino, D., Terriac, E., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3284 · Cited by 220
Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells
León, B., Ballesteros-Tato, A., Browning, J. L., Dunn, R., Randall, T. D., & Lund, F. E. (2012) · Nature Immunology · doi:10.1038/ni.2309 · Cited by 220
Draube, A., Klein-González, N., Mattheus, S., Brillant, C., Hellmich, M., Engert, A., & von Bergwelt-Baildon, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018801 · Cited by 214
“The need of a sufficient amount of vaccinated DC to enable activation of effector cells has already been suggested not only in murine models [75], but also in clinical trials [76].”
Mast cell activators: a new class of highly effective vaccine adjuvants
McLachlan, J. B., Shelburne, C. P., Hart, J. P., Pizzo, S. V., Goyal, R., Brooking-Dixon, R., Staats, H. F., & Abraham, S. N. (2008) · Nature Medicine · doi:10.1038/nm1757 · Cited by 206
Tumor-induced stromal reprogramming drives lymph node transformation
Riedel, A., Shorthouse, D., Haas, L., Hall, B. A., & Shields, J. (2016) · Nature Immunology · doi:10.1038/ni.3492 · Cited by 204
Regulation of Dendritic Cell Trafficking by the ADP-Ribosyl Cyclase CD38
Partida-Sánchez, S., Goodrich, S., Kusser, K., Oppenheimer, N., Randall, T. D., & Lund, F. E. (2004) · Immunity · doi:10.1016/s1074-7613(04)00048-2 · Cited by 206
Guarda, G., Hons, M., Soriano, S. F., Huang, A. Y., Polley, R., Martín-Fontecha, A., Stein, J. V., Germain, R. N., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1469 · Cited by 205
“It will be important to determine whether CXCL9 is produced directly by HEVs or by tissue cells and/or by migrating activated DC”
BackgroundSelf-citationDendritic-cell-based therapeutic vaccination against cancer
Nestle, F. O., Farkas, A., & Conrad, C. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.02.003 · Cited by 199
“An innovative and novel approach to the delivery of DCs is the conditioning of skin using pro-inflammatory agents (such as Toll-like receptor [TLR] agonists or pro-inflammatory cytokines) as an adjuvant followed by injection of DCs into the inflamed tissue [43,44 ].”
BackgroundCrucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking
Katagiri, K., Ohnishi, N., Kabashima, K., Iyoda, T., Takeda, N., Shinkai, Y., Inaba, K., & Kinashi, T. (2004) · Nature Immunology · doi:10.1038/ni1111 · Cited by 197
“After stimulation with LPS (1 μg/ml) for 24 h, differential labeling of bone marrow–derived DCs was done as described above, and equal numbers of labeled bone marrow–derived DCs from wild-type and RAPL-deficient mice were mixed (2 × 10 6 each per 50 μl of PBS) and were injected subcutaneously into footpads as describe”
Johnson, L. A., Banerji, S., Lawrance, W., Gileadi, U., Prota, G., Holder, K. A., Roshorm, Y. M., Hanke, T., Cerundolo, V., Gale, N. W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3750 · Cited by 197
Dendritic cells: a journey from laboratory to clinic
Cerundolo, V., Hermans, I. F., & Salio, M. (2004) · Nature Immunology · doi:10.1038/ni0104-7 · Cited by 194
Regulation of lymph node vascular growth by dendritic cells
Webster, B., Ekland, E. H., Agle, L. M., Chyou, S., Ruggieri, R., & Lu, T. T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052272 · Cited by 194
“Consistent with a previous study (43), the injection of LPS-matured BMDCs into the footpad led to an accumulation of BMDCs in the popliteal lymph node (Fig.”
BackgroundResultCross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
Gutiérrez-Martínez, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00363 · Cited by 175
Taming cancer by inducing immunity via dendritic cells
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00575.x · Cited by 189
“In particular, CD81 T cells need to be multifunctional at the level of cytokine secretion, as only those capable of secreting several cytokines, including IFN-g, TNF, and IL-2, can control HIV viral load (95).”
BackgroundInfluentialJohnson, L. A., & Jackson, D. G. (2010) · International Immunology · doi:10.1093/intimm/dxq435 · Cited by 191
Feig, J. E., Pineda-Torra, I., Sanson, M., Bradley, M. N., Vengrenyuk, Y., Bogunovic, D., Gautier, E. L., Rubinstein, D., Hong, C., Liu, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38911 · Cited by 185
Vigl, B., Aebischer, D., Nitschké, M., Iolyeva, M., Röthlin, T., Antsiferova, O., & Halin, C. (2011) · Blood · doi:10.1182/blood-2010-12-326447 · Cited by 190
Hallmarks of glioblastoma: a systematic review
Nørøxe, D. S., Poulsen, H. S., & Lassen, U. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000144 · Cited by 183
Beaty, S. R., Rose, C. E., & Sung, S.-S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1882 · Cited by 183
“These latter three chemokines are important in Ag-induced lung inflammation in inducing eosinophilia and in mediating macrophage and DC influx into lungs by their CCR3, CCR6, and CCR7 binding (31, 36, 66, 67).”
BackgroundFunctional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
Clausen, B. E., & Stoitzner, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00534 · Cited by 170
Dendritic cell trafficking: More than just chemokines
Sozzani, S. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.04.008 · Cited by 168
“CCR7 expression byDCwas shown to be required also for the entry of DC into lymphatic vessels at peripheral sites both in steady state and inflammatory conditions [55,56].”
BackgroundInfluentialLysosome signaling controls the migration of dendritic cells
Bretou, M., Sáez, P. J., Sanséau, D., Maurin, M., Lankar, D., Chabaud, M., Spampanato, C., Malbec, O., Barbier, L., Muallem, S., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aak9573 · Cited by 172
Engineered antibody fragments for immuno-PET imaging of endogenous CD8 + T cells in vivo
Tavaré, R., McCracken, M. N., Zettlitz, K. A., Knowles, S. M., Salazar, F. B., Olafsen, T., Witte, O. N., & Wu, A. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316922111 · Cited by 166
“(2003) Differential uptake of (18)F-fluorodeoxyglucose by experi-”
BackgroundInfluentialMarinkovic, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28993 · Cited by 164
“An important role for CCR7 in the migration of DCs into lymph nodes is well documented (30, 35).”
BackgroundInnate control of adaptive immunity: Dendritic cells and beyond
Lee, H. K., & Iwasaki, A. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.001 · Cited by 168
Dendritic Cells Distinguish Individual Chemokine Signals through CCR7 and CXCR4
Ricart, B. G., John, B., Lee, D., Hunter, C. A., & Hammer, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002358 · Cited by 168
“this interaction is based on histological studies that showed that CCL21 colocalized with lymphatic endothelial cells (17) and upregulation of CCL21 on those cells during inflammation (18).”
MethodZhivaki, D., Borriello, F., Chow, O. A., Doran, B., Fleming, I., Theisen, D. J., Pallis, P., Shalek, A. K., Sokol, C. L., Zanoni, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108381 · Cited by 163
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration
Yen, J.-H., Khayrullina, T., & Ganea, D. (2008) · Blood · doi:10.1182/blood-2007-05-090613 · Cited by 163
Fine-tuning of dendritic cell biology by the TNF superfamily
deLuca, L. S., & Gommerman, J. L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3193 · Cited by 184
Harnessing Nanoparticles for Immunomodulation and Vaccines
Gomes, A., Mohsen, M., & Bachmann, M. (2017) · Vaccines · doi:10.3390/vaccines5010006 · Cited by 158
“In addition, NPs are also taken up by skin- or muscle-resident DCs, which causes DC maturation, leading to the upregulation of the chemokine receptor CCR7, a homing receptor that causes DCs to migrate to lymph nodes [80], where they arrive as fully mature DCs charged for T cell priming.”
BackgroundRitter, U., Meißner, A., Scheidig, C., & Körner, H. (2004) · European Journal of Immunology · doi:10.1002/eji.200324586 · Cited by 154
Chen, Y.-G., Choisy-Rossi, C.-M., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J., Roopenian, D. C., Wilson, S. B., & SERREZE, D. V. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1196 · Cited by 166
“In addition, T cell levels in lymph nodes (LNs) have been correlated to the number of residing DCs (39).”
BackgroundYewdall, A. W., Drutman, S. B., Jinwala, F., Bahjat, K. S., & Bhardwaj, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011144 · Cited by 151
“This percentage of DCs to migrate is consistent with findings from other groups [30,31,32,33].”
Result
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.